Comparative effectiveness of LABA-ICS versus LAMA as initial treatment in COPD targeted by blood eosinophils: a population-based cohort study

S Suissa, S Dell'Aniello, P Ernst - The Lancet Respiratory Medicine, 2018 - thelancet.com
Background Long-acting β 2 agonists (LABAs) and long-acting muscarinic antagonists
(LAMAs) are the recommended initial maintenance treatment for chronic obstructive …
被引用次数：98 相关文章

[引用][C] Comparative effectiveness of LABA-ICS versus LAMA as initial treatment in COPD targeted by blood eosinophils: a population-based cohort study

S Suissa, S Dell'Aniello, P Ernst - The Lancet Respiratory Medicine, 2018 - cir.nii.ac.jp
Comparative effectiveness of LABA-ICS versus LAMA as initial treatment in COPD targeted by
blood eosinophils: a population-based cohort study | CiNii Research CiNii 国立情報学研究所 …

Comparative effectiveness of LABA-ICS versus LAMA as initial treatment in COPD targeted by blood eosinophils: a population-based cohort study.

S Suissa, S Dell'Aniello, P Ernst - The Lancet. Respiratory Medicine, 2018 - europepmc.org
Background Long-acting β 2 agonists (LABAs) and long-acting muscarinic antagonists
(LAMAs) are the recommended initial maintenance treatment for chronic obstructive …

Comparative effectiveness of LABA-ICS versus LAMA as initial treatment in COPD targeted by blood eosinophils: a population-based cohort study

S Suissa, S Dell'Aniello, P Ernst - The Lancet. Respiratory …, 2018 - pubmed.ncbi.nlm.nih.gov
Background Long-acting β 2 agonists (LABAs) and long-acting muscarinic antagonists
(LAMAs) are the recommended initial maintenance treatment for chronic obstructive …

Comparative effectiveness of LABA-ICS versus LAMA as initial treatment in COPD targeted by blood eosinophils: a population-based cohort study

S Suissa, S Dell'Aniello, P Ernst - The Lancet Respiratory Medicine, 2018 - Elsevier
Background Long-acting β 2 agonists (LABAs) and long-acting muscarinic antagonists
(LAMAs) are the recommended initial maintenance treatment for chronic obstructive …

Comparative effectiveness of LABA-ICS versus LAMA as initial treatment in COPD targeted by blood eosinophils: a population-based cohort study

S Suissa, S Dell'Aniello, P Ernst - The Lancet Respiratory Medicine, 2018 - Elsevier
Background Long-acting β 2 agonists (LABAs) and long-acting muscarinic antagonists
(LAMAs) are the recommended initial maintenance treatment for chronic obstructive …